Anxiety Disorders Among Women: A Female Lifespan Approach

Anxiety symptoms may present differently between women and men as well as at different points in the female lifespan. The female lifespan includes distinct epochs of hormonal function, including puberty, the premenstruum, pregnancy or postpartum (in some women), and the menopausal transition. These stages give rise to important treatment considerations when treating anxiety among women. When making assessments, the clinician should consider reproductive events and hormonal status as well as sex differences in anxiety presentation. This review is structured to define major epochs of the female lifespan; provide a brief summary of the major anxiety disorders, with a focus on prevalence and presentation in the context of sex differences and at points in the female lifespan; describe potential biopsychosocial underpinnings of anxiety disorders among women; provide guidelines for assessment and differential diagnosis; and describe treatment options with attention to reproductive events such as pregnancy.

Perimenopause Anxiety: Causes, Symptoms, Treatment

Frontiers Sex and Time-of-Day Impact on Anxiety and Passive Avoidance Memory Strategies in Mice

Lifespan Approach Penn PROMOTES Research on Sex and Gender in

Poster Presentation & Awards Center for Women's Health Research

The Link Between Hormones and Anxiety

The impact of the ovarian cycle on anxiety, allopregnanolone, and

Association between nonbirthing parent's perinatal education and mental health support desires and perinatal anxiety among either parent - ScienceDirect

The impact of the ovarian cycle on anxiety, allopregnanolone, and corticotropin releasing hormone changes after motherhood in female rats and women

Frontiers The Differential Role of Cytokines on Stress Responses in a Menopause Rat Model